Benign prostatic hyperplasia
Adult: 25-75 mg daily.
Indications and Dosage
Oral
Benign prostatic hyperplasia Adult: 25-75 mg daily.
|
Special Precautions
Not intended for use in women.
|
Adverse Reactions
Intraoperative floppy iris syndrome, ejaculatory disorders, buzzing or lightheadedness, hypotension.
|
Action
Description:
Mechanism of Action: Naftopidil is a peripheral α1-adrenergic receptor antagonist used to treat lower urinary tract symptoms. Pharmacokinetics: Metabolism: Undergoes hepatic metabolism by CYP2C9 and CYP3A4 isoenzymes. Excretion: Via bile. |
MIMS Class
|
References
Buckingham R (ed). Naftopidil. Martindale: The Complete Drug Reference [online]. London. Pharmaceutical Press. https://www.medicinescomplete.com
. Accessed 23/09/2014.
|